
Loading, please wait...

Loading, please wait...

The UK Heel Fracture Trial was a pragmatic multicentre randomized study evaluating open reduction and internal fixation against nonoperative management for displaced intra-articular calcaneal fractures. The trial addressed a central orthopaedic controversy: whether reconstructing the subtalar joint surgically improves patient-centred outcomes enough to justify the wound and infection risks of an extensile approach. At long-term follow-up, the overall functional results did not demonstrate a clear benefit from ORIF. The study therefore helped shift the discussion from radiographic perfection toward the balance between functional benefit and treatment morbidity. Not every fracture pattern can be managed identically, and the trial excluded some patients with marked deformity or other indications for surgery. For clinicians, the practical takeaway is to reserve operative treatment for patients in whom the expected mechanical benefit is substantial. Soft-tissue assessment, fracture morphology and patient factors are as important as the CT appearance. The paper remains highly relevant to contemporary foot-and-ankle practice because it demonstrates that a technically successful operation is not necessarily the same as a better long-term patient outcome.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The UK Heel Fracture Trial was a pragmatic multicentre randomized study evaluating open reduction and internal fixation against nonoperative management for displaced intra-articular calcaneal fractures. The trial addressed a central orthopaedic controversy: whether reconstructing the subtalar joint surgically improves patient-centred outcomes enough to justify the wound and infection risks of an extensile approach. At long-term follow-up, the overall functional results did not demonstrate a clear benefit from ORIF. The study therefore helped shift the discussion from radiographic perfection toward the balance between functional benefit and treatment morbidity. Not every fracture pattern can be managed identically, and the trial excluded some patients with marked deformity or other indications for surgery. For clinicians, the practical takeaway is to reserve operative treatment for patients in whom the expected mechanical benefit is substantial. Soft-tissue assessment, fracture morphology and patient factors are as important as the CT appearance. The paper remains highly relevant to contemporary foot-and-ankle practice because it demonstrates that a technically successful operation is not necessarily the same as a better long-term patient outcome.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back